Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Epigenomic Profiling Advises Therapeutic Potential of Leukotriene Receptor Inhibitors for a Subset of Triple-Negative Breast Tumors.
Kalinkin AI, Sigin VO, Kuznetsova EB, Ignatova EO, Vinogradov II, Vinogradov MI, Vinogradov IY, Zaletaev DV, Nemtsova MV, Kutsev SI, Tanas AS, Strelnikov VV. Kalinkin AI, et al. Among authors: sigin vo. Int J Mol Sci. 2023 Dec 11;24(24):17343. doi: 10.3390/ijms242417343. Int J Mol Sci. 2023. PMID: 38139172 Free PMC article.
Genome-wide methylotyping resolves breast cancer epigenetic heterogeneity and suggests novel therapeutic perspectives.
Tanas AS, Sigin VO, Kalinkin AI, Litviakov NV, Slonimskaya EM, Ibragimova MK, Ignatova EO, Simonova OA, Kuznetsova EB, Kekeeva TV, Larin SS, Poddubskaya EV, Trotsenko ID, Rudenko VV, Karandasheva KO, Petrova KD, Tsyganov MM, Deryusheva IV, Kazantseva PV, Doroshenko AV, Tarabanovskaya NA, Chesnokova GG, Sekacheva MI, Nemtsova MV, Izhevskaya VL, Kutsev SI, Zaletaev DV, Strelnikov VV. Tanas AS, et al. Among authors: sigin vo. Epigenomics. 2019 May;11(6):605-617. doi: 10.2217/epi-2018-0213. Epub 2019 Feb 7. Epigenomics. 2019. PMID: 30729807 Free article.
DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer.
Sigin VO, Kalinkin AI, Nikolaeva AF, Ignatova EO, Kuznetsova EB, Chesnokova GG, Litviakov NV, Tsyganov MM, Ibragimova MK, Vinogradov II, Vinogradov MI, Vinogradov IY, Zaletaev DV, Nemtsova MV, Kutsev SI, Tanas AS, Strelnikov VV. Sigin VO, et al. Cancers (Basel). 2023 Mar 6;15(5):1630. doi: 10.3390/cancers15051630. Cancers (Basel). 2023. PMID: 36900421 Free PMC article.
DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer.
Sigin VO, Kalinkin AI, Kuznetsova EB, Simonova OA, Chesnokova GG, Litviakov NV, Slonimskaya EM, Tsyganov MM, Ibragimova MK, Volodin IV, Vinogradov II, Vinogradov MI, Vinogradov IY, Kutsev SI, Strelnikov VV, Zaletaev DV, Tanas AS. Sigin VO, et al. Sci Rep. 2020 Jun 8;10(1):9239. doi: 10.1038/s41598-020-66197-1. Sci Rep. 2020. PMID: 32514046 Free PMC article.